Immunohistochemistry (IHC) Market By Product, Application, End-Use and Geography 2018 – 2026

0
27

Acumen Research and Consulting has announced the addition of the “Immunohistochemistry (IHC) Market” report to their offering.

The Immunohistochemistry (IHC) Market Industry Report 2018 is an in depth study analyzing the current state of the Immunohistochemistry (IHC) Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Immunohistochemistry (IHC) Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Immunohistochemistry (IHC) Market also discusses the opportunity areas for investors.

Download Sample Report Copy From Here:

https://www.acumenresearchandconsulting.com/request-sample/1118

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Market Players as below:

  1. Hoffmann-La Roche AG, Abcam plc, Thermo Fisher Scientific, Inc., Agilent Technologies, PerkinElmer, Inc., Bio SB, Merck KGaA, Bio-Rad Laboratories, Inc., Danaher Corporation, and Cell Signaling Technology, Inc.

The major market segments of Global Immunohistochemistry (IHC) Market are as below:

Market By Product

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Market By Application

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Market By End-Use

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Ask Query Here: frank@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

Table Of Contents:

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Immunohistochemistry (IHC)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Immunohistochemistry (IHC) Market By Product
1.2.2.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Immunohistochemistry (IHC) Market Revenue Share By Product in 2017
1.2.2.3. Antibodies
1.2.2.4. Equipment
1.2.2.5. Reagents
1.2.2.6. Kits
1.2.2.7. Others
1.2.3. Immunohistochemistry (IHC) Market By Application
1.2.3.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Diagnostics
1.2.3.3. Drug Testing
1.2.3.4. Others
1.2.4. Immunohistochemistry (IHC) Market By End Users
1.2.4.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Hospitals and Diagnostic Laboratories
1.2.4.3. Research Institutes
1.2.4.4. Others
1.2.5. Immunohistochemistry (IHC) Market by Geography
1.2.5.1. Global Immunohistochemistry (IHC) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Immunohistochemistry (IHC) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Immunohistochemistry (IHC) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Immunohistochemistry (IHC) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Immunohistochemistry (IHC) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Immunohistochemistry (IHC) Major Manufacturers in 2017

CHAPTER 4. IMMUNOHISTOCHEMISTRY (IHC) MARKET BY PRODUCT

4.1. Global Immunohistochemistry (IHC) Revenue By Product
4.2. Antibodies
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Equipment
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Reagents
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Kits
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Other
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. IMMUNOHISTOCHEMISTRY (IHC) MARKET BY APPLICATION

5.1. Global Immunohistochemistry (IHC) Revenue By Application
5.2. Diagnostics
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Drug Testing
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. IMMUNOHISTOCHEMISTRY (IHC) MARKET BY END USERS

6.1. Global Immunohistochemistry (IHC) Revenue By End Users
6.2. Hospitals and Diagnostic Laboratories
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Research Institutes
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

7.1. North America Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Immunohistochemistry (IHC) Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

8.1. Europe Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

9.1. Asia-Pacific Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Mi+llion)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

10.1. Latin America Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

11.1. Middle East Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 12. AFRICA IMMUNOHISTOCHEMISTRY (IHC) MARKET BY COUNTRY

12.1. Africa Immunohistochemistry (IHC) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Africa Immunohistochemistry (IHC) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. F. Hoffmann-La Roche AG
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abcam plc
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Agilent Technologies
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Bio SB
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Merck KGaA
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Danaher Corporation
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Cell Signaling Technology, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1118

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.